Pfizer Stock Sees 1.48% Rise Amid Metsera Merger Tussle
Pharmaceutical giant Pfizer’s stock price surged on Friday due to its approval of a multibillion-dollar merger deal with rival company Metsera, despite Novo Nordisk making an unsolicited takeover bid. Novo Nordisk has filed a lawsuit in Delaware Chancery Court seeking to block the deal after Pfizer rejected its bid, citing that it is not reasonably … Read more